YM 43611
Latest Information Update: 10 Feb 1999
At a glance
- Originator Yamanouchi
- Class Antipsychotics; Benzamides
- Mechanism of Action Dopamine D3 receptor antagonists; Dopamine D4 receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Psychotic disorders
Most Recent Events
- 10 Feb 1999 Discontinued-Preclinical for Psychotic disorders in Japan (Unknown route)
- 12 Oct 1998 Profile reviewed
- 26 Oct 1995 Preclinical development for Psychotic disorders in Japan (Unknown route)